Zydus Lifesciences Buyback Latest News Today

November 20, 2024 5:14:00 PM

Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are already eying the blockbuster as a potential target. | The spinal muscular ...

July 10, 2024 4:29:00 PM

Shares of Zydus Lifesciences Ltd on Wednesday staged a sharp upmove during late deals. The stock recovered 4.98 per cent from an intraday low price of Rs 1,133.55 to hit an all-time high of Rs 1,190.

March 7, 2022 9:51:00 AM

CEAT, 5Paisa Capital, Quick Heal Technologies, Kotak Mahindra Bank, Nitco, Adani Enterprises, Aether Industries, Zydus Lifesciences, Coromandel International, and Mahanagar Telephone Nigam will ...

November 13, 2024 3:30:00 AM

Zydus Lifesciences (NSEI:ZYDUSLIFE) has reported strong earnings growth, with a 65% increase, positioning it as a leader in the pharmaceutical sector. Recent developments include the World Health ...

October 23, 2024 6:36:00 AM

Indian pharmaceutical company Zydus Lifesciences Limited announced today that its typhoid vaccine, ZyVac TCV, has received World Health Organization (WHO) prequalification, making it eligible for ...

October 31, 2023 3:00:00 PM

New Delhi, Zydus Lifesciences on Tuesday said it has acquired UK-based LiqMeds Group for GBP 68 million (around Rs 689 crore). The Ahmedabad-based group, through its wholly-owned subsidiary Zydus ...

November 13, 2024 6:52:00 AM

Zydus Lifesciences Ltd announced strong double-digit growth in line with estimates, on the back of sustained growth across its key businesses, in its consolidated financial results for the ...

August 11, 2023 11:27:00 AM

New Delhi, Zydus Lifesciences Ltd on Friday reported over two-fold rise in consolidated net profit at Rs 1,086.9 crore for the first quarter ended June 30, 2023 driven by strong sales growth from ...

November 12, 2024 10:06:00 AM

Indian drugmaker Zydus Lifesciences reported a 14% rise in second-quarter profit on Tuesday, helped by strong demand for generic drugs in its key United States and Indian markets.

February 24, 2022 5:08:00 PM

The US Food and Drug Administration (USFDA) conducted inspection at the injectables manufacturing facility between April 15 and April 23, 2024, Zydus Lifesciences said in a regulatory filing.